
NASDAQ · DHR
Danaher Corporation
Healthcare · Medical - Diagnostics & Research
$209.36
Up+$6.04 (+2.97%)
Updated Sep 16, 2026, 11:30 AM
SID Score
5.8/10
Composite research score
Smart Money
51/100
Neutral
- Market cap
- 166.5B
- P/E ratio
- 47.14
- Dividend yield
- 0.59%
- 52-week range
- $160.93 – $242.80
- Volume
- 3.51M
- Avg. volume
- 4.18M
Price performance
DHR price history
1M range · 20 trading sessions · Daily adjusted prices
DHR closed at $209.36 after 20 trading sessions, up 4.90% for the selected period.
- Last close
- $209.36
- Period change
- +4.90%
- Period low
- $199.58
- Period high
- $218.85
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $203.08 | $209.55 | $202.6201 | $209.36 | 3.51M |
| Sep 14, 2026 | $202.48 | $203.81 | $199.09 | $203.25 | 3.43M |
| Sep 11, 2026 | $201.99 | $202.68 | $199.16 | $200.14 | 3.63M |
| Sep 10, 2026 | $202.33 | $203.10 | $200.34 | $200.53 | 3.02M |
| Sep 9, 2026 | $206.00 | $206.05 | $201.95 | $204.85 | 2.77M |
| Sep 8, 2026 | $205.00 | $207.84 | $202.12 | $205.23 | 3.28M |
| Sep 4, 2026 | $207.19 | $208.70 | $205.23 | $207.66 | 2.9M |
| Sep 3, 2026 | $210.51 | $213.13 | $206.05 | $211.03 | 2.42M |
| Sep 2, 2026 | $207.77 | $212.7793 | $206.10 | $209.91 | 2.95M |
| Sep 1, 2026 | $214.74 | $215.00 | $206.55 | $206.93 | 3.15M |
| Aug 31, 2026 | $213.45 | $215.385 | $212.22 | $213.56 | 3.61M |
| Aug 28, 2026 | $215.10 | $217.04 | $212.8502 | $216.07 | 2.86M |
| Aug 27, 2026 | $214.78 | $218.57 | $213.092 | $215.68 | 2.93M |
| Aug 26, 2026 | $213.23 | $216.8499 | $212.81 | $215.36 | 2.53M |
| Aug 25, 2026 | $213.88 | $216.77 | $212.24 | $215.97 | 2.34M |
| Aug 24, 2026 | $218.33 | $218.34 | $213.88 | $215.11 | 2.51M |
| Aug 21, 2026 | $215.58 | $220.25 | $213.46 | $218.85 | 4.7M |
| Aug 20, 2026 | $210.12 | $220.67 | $208.21 | $215.91 | 5.5M |
| Aug 19, 2026 | $203.10 | $212.19 | $202.905 | $211.50 | 5.25M |
| Aug 18, 2026 | $203.97 | $204.23 | $199.49 | $199.58 | 2.29M |
Latest DHR news
The latest Smart Investors Daily articles mentioning DHR.

